Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis

Šućur, Alan and Katavić, Vedran and Kelava, Tomislav and Jajić, Zrinka and Kovačić, Nataša and Grčević, Danka (2014) Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis. International Orthopaedics, 38 (9). pp. 1893-1903. ISSN 0341-2695

PDF - Accepted Version
Download (395kB) | Preview


The inflammatory milieu favors recruitment and activation of osteoclasts, and leads to bone destruction as a serious complication associated with arthritis and with other inflammatory processes. The frequency and activity of osteoclast progenitors (OCPs) correspond to arthritis severity, and may be used to monitor disease progression and bone resorption, indicating the need for detailed characterization of the discrete OCP subpopulations. Collectively, current studies suggest that the most potent murine bone marrow OCP population can be identified among lymphoid negative population within the immature myeloid lineage cells, as B220(-)CD3(-)CD11b(-/lo)CD115(+)CD117(+)CX3CR1(+) and possibly also Ter119(-)CD11c(-)CD135(lo)Ly6C(+)RANK(-). In peripheral blood the OCP population bears the monocytoid phenotype B220(-)CD3(-)NK1.1(-)CD11b(+)Ly6C(hi)CD115(+)CX3CR1(+), presumably expressing RANK in committed OCPs. Much less is known about human OCPs and their regulation in arthritis, but the circulating OCP subset is, most probably, comprised among the lymphoid negative population (CD3(-)CD19(-)CD56(-)), within immature monocyte subset (CD11b(+)CD14(+)CD16(-)), expressing receptors for M-CSF and RANKL (CD115(+)RANK(+)). Our preliminary data confirmed positive association between the proportion of peripheral blood OCPs, defined as CD3(-)CD19(-)CD56(-)CD11b(+)CD14(+), and the disease activity score (DAS28) in the follow-up samples from patients with psoriatic arthritis receiving anti-TNF therapy. In addition, we reviewed cytokines and chemokines which, directly or indirectly, activate OCPs and enhance their differentiation potential, thus mediating osteoresorption. Control of the activity and migratory behaviour of OCPs as well as the identification of crucial bone/joint chemotactic mediators represent promising therapeutic targets in arthritis.

Item Type: Article
MeSH: Animals ; Arthritis/pathology ; Arthritis/physiopathology ; Bone Resorption/pathology ; Cell Differentiation/physiology ; Cell Lineage ; Chemokines/physiology ; Cytokines/physiology ; Disease Models, Animal ; Humans ; Mice ; Osteoclasts/pathology ; Severity of Illness Index ; Stem Cells/pathology
Departments: Katedra za anatomiju i kliničku anatomiju
Katedra za fizikalnu medicinu i rehabilitaciju
Katedra za fiziologiju i imunologiju
Depositing User: Marijan Šember
Status: Published
Katavić, VedranUNSPECIFIED
Kelava, TomislavUNSPECIFIED
Kovačić, NatašaUNSPECIFIED
Date: September 2014
Date Deposited: 10 Dec 2015 13:38
Last Modified: 20 Jul 2020 08:49
Subjects: /
Related URLs:

Actions (login required)

View Item View Item


Downloads per month over past year